Vascular inflammation and sleep disordered breathing in a community-based cohort

Sleep

Volumn 36, Issue 5, 2013, Pages 763-768

  Chami, Hassan A ^a,b   Fontes, João D ^b   Vasan, Ramachandran S ^b,c   Keaney, John F ^d   O'Connor, George T ^b   Larson, Martin G ^c,e   Benjamin, Emelia J ^b,c,e   Gottlieb, Daniel J ^b,f  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Epidemiology; Inflammation; Sleep apnea syndromes

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYHEMOGLOBIN; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; APNEA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; VASCULITIS;

EID: 84877115710     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2644     Document Type: Article

References (44)

1. Peppard PE, Young T, Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
2. Shahar E, Whitney CW, Redline S, et al Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heat Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
3. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004; 113: e564-9.
4. Larkin EK, Rosen CL, Kirchner H.L., et al Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005; 111: 1978-84.
5. Shamsuzzaman AS, Winnicki M, Lanfranchi P., et al Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.
6. Teramoto S, Yamamoto H, Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 2003; 107: E40-0.
7. Zouaoui BK, Van Meerhaeghe A, Doumit S, et al Sleep apnoeahypop-noea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration 2006; 73: 243-6.
8. Minoguchi K, Yokoe T, Tazaki T., et al Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 625-30.
9. Punjabi N, Beamer B. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007; 30: 29-34.
10. Vgontzas AN, Papanicolaou DA, Bixler E.O., Kales A., Tyson K, Chrousos GP Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-6.
11. Yokoe T, Minoguchi K, Matsuo H., et al Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-34.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 15-26.
13. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-9.
14. Reynolds GD, Vance RP C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987; 111: 265-9.
15. Poston RN, Haskkard DO, Coucher H.R., Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140: 665-73.
16. Nelken NA, Coughlin SR, Gordon D, Wilcox JN Monocyte che-moattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-7.
17. Tracy RP, Lemaitre RN, Psaty B.M., et al Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-7.
18. Ridker PM, Hennekens CH, Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
19. Ridker PM, Rifai N, Stampfer M.J., Hennekens CH Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-72.
20. Koukkunen H, Penttila K, Kemppainen A., et al C-reactive protein, fi-brinogen, interleukin-6 and tumor necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001; 33: 37-47.
21. Harris TB, Ferrucci L, Tracy R.P., et al Associations of elevated interleu-kin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506-12.
22. Kaditis AG, Alexopoulos EI, Kalampouka E, et al Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005; 171: 282-6.
23. Barcelo A, Barbe F, Llompart E., et al Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004; 117: 118-21.
24. Can M, Acikgoz S, Mungan G., et al Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006; 129: 233-7.
25. Guilleminault C, Kirisoglu C, Ohayon MM C-reactive protein and sleep-disordered breathing. Sleep 2004; 27: 1507-11.
26. Akashiba T, Akahoshi T, Kawahara S., Majima T, Horie T. Effects of longterm nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44: 899-900.
27. Saletu M, Nosiska D, Kapfhammer G., et al Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol 2006; 253: 746-52.
28. Taheri S, Austin D, Lin L., Nieto J, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007; 30: 991-6.
29. Mehra R, Storfer-Isser A, Kirchner L., et al Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 2006; 166: 1725-31.
30. Kohler M, Ayers L, Pepperell JCT, et al Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009; 64: 67-73.
31. Drager LF, Bortolotto LA, Figueiredo A.C., et al Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176: 706-12.
32. Ohga E, Nagase T, Tomita T., et al Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87: 10-4.
33. O'Brien L.M., Serpero LD, Tauman R, Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 2006; 129: 947-53.
34. Akinnusi ME, Paasch LL, Szarpa K.R., Wallace PK, El Solh AA. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 2009; 77: 18-20.
35. Quan SF, Howard B V, Iber C, et al The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997; 20: 1077-85.
36. Kannel WB, Feinleib M, McNamara P.M., Garrison RJ, Castelli WP An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979; 110: 281-90.
37. Schnabel R, Larson MG, Dupuis J, et al Relations of inflammatory bio-markers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008; 51: 1651-7.
38. Whitney CW, Gottlieb DJ, Redline S, et al Reliability of scoring respiratory disturbance indices and sleep staging. Sleep 1998; 21: 749-57.
39. Redline S, Sanders MH, Lind B.K., et al Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep 1998; 21: 759-67.
40. Quan SF, Griswold ME, Iber C, et al Short-term variability of respiration and sleep during unattended nonlaboratory polysomnography-The Sleep Heart Health Study. Sleep 2002; 25: 843-49.
41. Yudkin JS, Kumari M, Humphries S.E., et al Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-14.
42. Greenberg H, Ye X, Wilson D., Htoo AK, Hendersen T, Liu SF Chronic intermittent hypoxia activates nuclear factor-kappa-B in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006; 343: 591-6.
43. Vgontaz AN, Zoumakis E, Bixler E.O., et al Adverse effects of modest sleep deprivation on sleepiness performance and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-26.
44. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278: 45777-84.